Annual Drug Patent Expirations for NEXAVAR
Nexavar is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for NEXAVAR.
This drug has ninety-two patent family members in thirty-nine countries.
The generic ingredient in NEXAVAR is sorafenib tosylate. One supplier is listed for this compound. Additional details are available on the sorafenib tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
